These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29778308)

  • 1. Meeting report of the "Regulatory Exchange Matters" session at the 5th International TREAT-NMD Conference:: Lessons in communication: How an early dialogue between patients, regulators and academics can further therapy development for neuromuscular disorders Freiburg, Germany, 27-29 November 2017.
    Aartsma-Rus A; Mercuri E; Vroom E; Balabanov P
    Neuromuscul Disord; 2018 Jul; 28(7):619-623. PubMed ID: 29778308
    [No Abstract]   [Full Text] [Related]  

  • 2. Facilitating orphan drug development: Proceedings of the TREAT-NMD International Conference, December 2015, Washington, DC, USA.
    Hoffman EP; ;
    Neuromuscul Disord; 2017 Jul; 27(7):693-701. PubMed ID: 28434909
    [No Abstract]   [Full Text] [Related]  

  • 3. Report on the 5th Ottawa International Conference on Neuromuscular Disease & Biology -October 17-19, 2019, Ottawa, Canada.
    Warman-Chardon J; Jasmin BJ; Kothary R; Parks RJ
    J Neuromuscul Dis; 2021; 8(2):323-334. PubMed ID: 33492242
    [No Abstract]   [Full Text] [Related]  

  • 4. [Myogenic and neuromuscular diseases. Panel discussion at the 75th session of the German Society for Pediatrics, 4-6 September 1978, Freiburg].
    Monatsschr Kinderheilkd (1902); 1980 Feb; 128(2):55-80. PubMed ID: 7360131
    [No Abstract]   [Full Text] [Related]  

  • 5. Sleep disorders in neuromuscular diseases.
    Dhand UK; Dhand R
    Curr Opin Pulm Med; 2006 Nov; 12(6):402-8. PubMed ID: 17053488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Threading Granules in Freiburg. 2
    Braun RJ; Zerbes RM; Steinberg F; Gris D; Dumit VI
    Microb Cell; 2016 Nov; 3(11):565-568. PubMed ID: 28357325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring quality of life in people with slowly-progressive neuromuscular disease.
    Dany A; Rapin A; Réveillère C; Calmus A; Tiffreau V; Morrone I; Novella JL; Jolly D; Boyer FC
    Disabil Rehabil; 2017 Jun; 39(13):1262-1270. PubMed ID: 27342814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal method for assessment of respiratory muscle strength in neuromuscular disorders using sniff nasal inspiratory pressure (SNIP).
    Kaminska M; Noel F; Petrof BJ
    PLoS One; 2017; 12(5):e0177723. PubMed ID: 28520769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory management of acute respiratory failure in neuromuscular diseases.
    Racca F; Del Sorbo L; Mongini T; Vianello A; Ranieri VM
    Minerva Anestesiol; 2010 Jan; 76(1):51-62. PubMed ID: 20125073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of assessing quality of life in patients with neuromuscular disorders.
    Carter GT; Han JJ; Abresch RT; Jensen MP
    Am J Hosp Palliat Care; 2006 Dec-2007 Jan; 23(6):493-7. PubMed ID: 17211006
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of a tool to guide referral of patients with neuromuscular disorders to allied health services. Part one.
    Pieterse AJ; Cup EH; Knuijt S; Hendricks HT; van Engelen BG; van der Wilt GJ; Oostendorp RA
    Disabil Rehabil; 2008; 30(11):855-62. PubMed ID: 17852320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term follow-up of ventilated patients with thoracic restrictive or neuromuscular disease.
    Brooks D; De Rosie J; Mousseau M; Avendaño M; Goldstein RS
    Can Respir J; 2002; 9(2):99-106. PubMed ID: 11972163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise therapy and other types of physical therapy for patients with neuromuscular diseases: a systematic review.
    Cup EH; Pieterse AJ; Ten Broek-Pastoor JM; Munneke M; van Engelen BG; Hendricks HT; van der Wilt GJ; Oostendorp RA
    Arch Phys Med Rehabil; 2007 Nov; 88(11):1452-64. PubMed ID: 17964887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of patient advocacy organisations in neuromuscular disease R&D--The case of the Dutch neuromuscular disease association VSN.
    Boon W; Broekgaarden R
    Neuromuscul Disord; 2010 Feb; 20(2):148-51. PubMed ID: 20106662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular hypertrabeculation/noncompaction with and without neuromuscular disorders.
    Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J
    Int J Cardiol; 2004 Oct; 97(1):89-92. PubMed ID: 15336813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the ICF core set for neuromuscular diseases.
    Bos I; Stallinga HA; Middel B; Kuks JB; Wynia K
    Eur J Phys Rehabil Med; 2013 Apr; 49(2):179-87. PubMed ID: 23172408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of scoliosis on respiratory muscle strength in patients with neuromuscular disorders.
    Inal-Ince D; Savci S; Arikan H; Saglam M; Vardar-Yagli N; Bosnak-Guclu M; Dogru D
    Spine J; 2009 Dec; 9(12):981-6. PubMed ID: 19819188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational Research in Europe for the Assessment and Treatment for Neuromuscular Disorders (TREAT-NMD).
    Leary R; Oyewole AO; Bushby K; Aartsma-Rus A
    Neuropediatrics; 2017 Aug; 48(4):211-220. PubMed ID: 28683502
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessing oral literacy demand in genetic counseling dialogue: preliminary test of a conceptual framework.
    Roter DL; Erby LH; Larson S; Ellington L
    Soc Sci Med; 2007 Oct; 65(7):1442-57. PubMed ID: 17614177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic indicators of neuromuscular disorders for palliative care referral.
    Chang RS; Wong YK
    Ann Palliat Med; 2018 Jul; 7(3):335-338. PubMed ID: 29156911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.